| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |